Symbol
| SLC25A4
| contributors: mct - updated : 11-04-2015
|
HGNC name
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
HGNC id
| 10990
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in muscle of FSH myopathy, and mitochondrial dysfunction may thus be initial events in FSHD | tumoral
|  
|  
|  
|  
|
silencing induces oxidative stress and programmed cell death in glioblastoma cells | constitutional
|  
|  
| --other
|  
|
dysregulation of acetylation of mitochondrial proteins such as SLC25A4 therefore could be related to changes in mitochondrial function that are associated with insulin resistance.e | constitutional
|  
|  
| --low
|  
|
in sporadic inclusion body myositis | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neuromuscular | myopathy | congenital | |
increased expression represent potential therapeutic target in FSHD |
| | | |
| Ant1 mice develop mitochondrial myopathy associated with ragged-red fibers and abnormal mitochondria and a hypertrophic cardiopathy |